DE3880758D1 - Von monozyten abstammendes gefaesswirksames protein und dessen analogen, verfahren zu seiner gewinnung und ihre verwendungen fuer therapeutische zwecke und zur antikoerperherstellung. - Google Patents

Von monozyten abstammendes gefaesswirksames protein und dessen analogen, verfahren zu seiner gewinnung und ihre verwendungen fuer therapeutische zwecke und zur antikoerperherstellung.

Info

Publication number
DE3880758D1
DE3880758D1 DE8888402068T DE3880758T DE3880758D1 DE 3880758 D1 DE3880758 D1 DE 3880758D1 DE 8888402068 T DE8888402068 T DE 8888402068T DE 3880758 T DE3880758 T DE 3880758T DE 3880758 D1 DE3880758 D1 DE 3880758D1
Authority
DE
Germany
Prior art keywords
monocytes
thr
ser
analogs
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888402068T
Other languages
English (en)
Other versions
DE3880758T2 (de
Inventor
Jean-Luc Wautier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IVS Institut des Vaisseaux et du Sang
Original Assignee
IVS Institut des Vaisseaux et du Sang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IVS Institut des Vaisseaux et du Sang filed Critical IVS Institut des Vaisseaux et du Sang
Application granted granted Critical
Publication of DE3880758D1 publication Critical patent/DE3880758D1/de
Publication of DE3880758T2 publication Critical patent/DE3880758T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE8888402068T 1987-08-12 1988-08-09 Von monozyten abstammendes gefaesswirksames protein und dessen analogen, verfahren zu seiner gewinnung und ihre verwendungen fuer therapeutische zwecke und zur antikoerperherstellung. Expired - Fee Related DE3880758T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8711490A FR2619383B1 (fr) 1987-08-12 1987-08-12 Proteine a activite vasculaire, derivee des monocytes et ses analogues, procede pour son extraction et leurs utilisations en therapeutique et pour la preparation d'anticorps

Publications (2)

Publication Number Publication Date
DE3880758D1 true DE3880758D1 (de) 1993-06-09
DE3880758T2 DE3880758T2 (de) 1993-08-19

Family

ID=9354140

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888402068T Expired - Fee Related DE3880758T2 (de) 1987-08-12 1988-08-09 Von monozyten abstammendes gefaesswirksames protein und dessen analogen, verfahren zu seiner gewinnung und ihre verwendungen fuer therapeutische zwecke und zur antikoerperherstellung.

Country Status (6)

Country Link
US (1) US5071956A (de)
EP (1) EP0303538B1 (de)
JP (1) JPH01104100A (de)
AT (1) ATE89007T1 (de)
DE (1) DE3880758T2 (de)
FR (1) FR2619383B1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312315D0 (en) * 1993-06-15 1993-07-28 Poston Robin Leukocyte adhesion assay
US5441986A (en) * 1994-07-19 1995-08-15 Pfizer Inc. Estrogen agonists as remedies for prostate and cardiovascular diseases
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells

Also Published As

Publication number Publication date
DE3880758T2 (de) 1993-08-19
EP0303538A3 (en) 1989-03-29
EP0303538A2 (de) 1989-02-15
US5071956A (en) 1991-12-10
FR2619383A1 (fr) 1989-02-17
JPH01104100A (ja) 1989-04-21
FR2619383B1 (fr) 1989-12-08
EP0303538B1 (de) 1993-05-05
ATE89007T1 (de) 1993-05-15

Similar Documents

Publication Publication Date Title
Langeveld et al. Structural heterogeneity of the noncollagenous domain of basement membrane collagen.
ATE309360T1 (de) Vaskularer endothelialer wachstumsfaktor 2
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
DE68926888D1 (de) Verfahren zur Herstellung von sekretierten Rezeptoranalogen
KR900002752A (ko) 히루딘-피복 생체 적합성 물질 및 이의 제조방법
ATE367398T1 (de) Verfahren zur rückfaltung von proteinen mit freien cysteinresten
ATE99330T1 (de) Rekombinantes viren-ueberzugsprotein assoziiert mit ''acquired immune deficiency syndrome'' (aids) und verfahren zur testung von aids.
ATE170630T1 (de) Proteine mit geänderten epitopen und verfahren zur deren herstellung
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
DE68925226D1 (de) Monoklonale Antikörper
DE69836139D1 (de) Verfahren zur behandlung von vaskulären proliferativen erkrankungen mit p27 und fusionen davon
KR900002795A (ko) 하이브리드 단백질c 작제물 및 그들의 제조방법
BG49827A3 (en) Method for preparing a clean byologic active recombinative human colonium stimulating factor
DE69823501D1 (de) Verwendung von wolinella succinogenes asparaginase zur behandlung von asparagin-abhängiger krankheiten
HUP0100456A1 (hu) IFNAR2/IFN komplex, alkalmazásai és a komplexet tartalmazó készítmények
EE05497B1 (et) Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha
DE3888998D1 (de) Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten.
ATE275968T1 (de) Mitteln zur behandlung von auto-immun krankheiten
DE3880758D1 (de) Von monozyten abstammendes gefaesswirksames protein und dessen analogen, verfahren zu seiner gewinnung und ihre verwendungen fuer therapeutische zwecke und zur antikoerperherstellung.
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
Furthmayr Immunochemistry of the extracellular matrix
DK0683791T3 (da) Vandig proteinsammensætning, glycoprotein indeholdt deri, fremgangsmåde til opnåelse deraf og anvendelser deraf
ATE55059T1 (de) Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen.
DE58907746D1 (de) Verfahren zur Bestimmung von Fructosamin.
Frazier et al. Structure of human thrombospondin: complete amino acid sequence derived from cDNA

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee